Peak Expiratory Flow (PEF) for Vital Signs Assessment
PEF should NOT be incorporated into routine vital sign assessment as it is inferior to FEV1 for objective measurement of airway obstruction and lacks the reliability needed for standard vital sign monitoring. 1
Role of PEF in Clinical Practice
Primary Limitations
PEF has significant drawbacks that prevent it from being a standard vital sign:
Cannot differentiate obstruction from restriction - Unlike spirometry with FEV1/FVC ratio, PEF measurements alone cannot determine if low values result from obstructive or restrictive lung disease 1
Poor correlation with FEV1 - In COPD, the relationship between PEF and FEV1 is poor, making it impossible to predict one from the other 1
Underestimates obstruction severity - PEF may significantly underestimate the degree of airways obstruction, particularly in COPD and advanced emphysema 1, 2
High variability - There is considerable variability between FEV1 and PEF when expressed as percentage predicted values, with FEV1% predicted typically 10-35% lower than PEF% predicted 3, 4
Appropriate Clinical Uses
PEF is most valuable for serial home monitoring in individual patients, particularly those with asthma, rather than as a routine vital sign 5:
For Asthma Monitoring:
- Technique: Patient stands and blows as hard as possible through disposable mouthpiece; best of three attempts recorded 5
- Normal values: Compare to normative data charts based on sex, age, and height 5
- Bronchodilator response: 20% increase AND absolute improvement of 60 L/min suggests asthma 5
- Daily variability: >10% in adults or >13% in children suggests asthma 5
Serial Monitoring Parameters:
- Record twice daily (morning and evening, before treatment) for minimum one week 6
- Calculate average from at least 5 days of recordings 6
- Response definition: Increase >15% over baseline PEF indicates meaningful change 6
Values Defining Airway Obstruction Severity
Critical Caveat
PEF should NOT be used to classify severity of airflow obstruction except in mild cases 7. The consistency between PEF and FEV1 for grading severity is only acceptable for mild obstruction (Kappa 0.671), but moderate or poor for moderate, severe, and extremely severe obstruction 7.
When PEF Must Be Used (Asthma Context):
For acute asthma exacerbations 8:
- Severe: PEF <40% predicted
- Moderate: PEF 40-69% predicted
- Mild: PEF ≥70% predicted
Screening Thresholds for COPD:
- PEF <80% predicted has sensitivity of 76.8-85.3% and specificity of 81.4-83.8% for detecting airflow obstruction 9
- Best used as screening tool when spirometry unavailable, not for severity classification 9, 7
Common Pitfalls to Avoid
Never assume PEF and FEV1 are equivalent - Agreement in classification occurs in only 49.9% of paired measurements 4
Don't rely on PEF in advanced emphysema - PEF may be only moderately reduced while FEV1 is severely affected 2
Avoid single measurements - PEF requires serial measurements over days to weeks for meaningful interpretation 6, 5
Don't use for COPD severity grading - Except for mild obstruction, PEF is not an appropriate alternative to FEV1 for classifying severity 7
Bottom Line for Clinical Practice
Use spirometry with FEV1 for objective assessment of airway obstruction in clinical settings. Reserve PEF for home monitoring in asthma patients where serial measurements can detect variability and response to treatment, or as a screening tool when spirometry is genuinely unavailable 1, 5. PEF lacks the precision, reproducibility, and prognostic value needed for routine vital sign assessment or severity classification.